郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

肿瘤模型Novel anti-CD20 antibody TGLA with enhanced antibody-dependent cell-mediated cytotoxicity mediates potent anti-lymphoma activity.

期刊：Cancer letters发表年份：2010作者：Ming Lv; Zhou Lin; Chunxia Qiao; Shusheng Gen; Xiaoling Lang; Yan Li; Jiannan Feng; Beifen Shen
阅读更多 →

肿瘤模型First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis.

期刊：Journal of medicinal chemistry发表年份：2010作者：Benoît Laleu; Francesca Gaggini; Mike Orchard; Laetitia Fioraso-Cartier; Laurène Cagnon; Sophie Houngninou-Molango; Angelo Gradia; Guillaume Duboux; Cédric Merlot; Freddy Heitz; Cédric Szyndralewiez; Patrick Page
阅读更多 →

肿瘤模型Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer.

期刊：International journal of cancer发表年份：2010作者：Martin E Eichhorn; Ivan Ischenko; Siiri Luedemann; Sebastian Strieth; Armine Papyan; Alexander Werner; Hermann Bohnenkamp; Eric Guenzi; Gerhard Preissler; Uwe Michaelis; Karl-Walter Jauch; Christiane J Bruns; Marc Dellian
阅读更多 →

肿瘤模型In vivo and in vitro anti-cancer activities and enhanced cellular uptakes of EGF fragment decorated doxorubicin nano-aggregates.

期刊：International journal of pharmaceutics发表年份：2010作者：Shinyoung Park; Hyuk Sang Yoo
阅读更多 →